Kerry S. Courneya

Country flagCanada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Supplementary Table S4 shows that patients with an RHR ≥88 bpm had higher risks of all-cause and CRC-specific mortality compared to those with an RHR ≤66 bpm, after excluding patients who received neoadjuvant therapy.

Year:

2025

Supplementary Table S3 shows that patients with an RHR ≥88 bpm had higher risks of all-cause and CRC-specific mortality compared to those with an RHR ≤66 bpm, after excluding patients with a history of disease.

Year:

2025

Supplementary Table S2 shows that patients with an RHR ≥88 bpm had higher risks of all-cause and CRC-specific mortality compared to those with an RHR ≤66 bpm, after excluding patients who had died within 3-month of surgery.

Year:

2025

Background: Although lifestyle factors are associated with resting heart rate (RHR), its association with mortality in patients with colorectal cancer has not been fully understood. Therefore, we sought to determine whether RHR is associated with all-cause and colorectal cancer–specific mortality in patients with stage I to III colorectal cancer. Methods: We included a total of 3,631 patients from the Severance Hospital Colorectal Cancer Registry (Seoul, South Korea) who underwent surgery for stage I to III colorectal cancer. RHR data were collected on the day of surgery. We utilized multivariable Cox proportional hazards models to estimate HRs and 95% confidence intervals (CI) for the association between RHR and all-cause and colorectal cancer–specific mortality. Results: During a median follow-up of 3.0 years, there were 292 all-cause and 177 colorectal cancer–specific deaths. Patients in the highest quintile of RHR [≥88 beats per minute (bpm)] versus patients in the lowest quintile of RHR (≤66 bpm) showed a 3.33-fold increased risk of all-cause mortality (95% CI, 1.85–5.99) and a 2.98-fold increased risk of colorectal cancer–specific mortality (95% CI, 1.72–5.16). For every 10-bpm increase in RHR, there was a 1.44-fold increase in all-cause mortality (95% CI, 1.32–1.58) and a 1.50-fold increase in colorectal cancer–specific mortality (95% CI, 1.33–1.69). Conclusions: Elevated RHR on the day of surgery for colorectal cancer is associated with a higher risk of all-cause/colorectal cancer–specific mortality. Impact: Our data suggest that RHR may serve as a clinically relevant predictor of mortality in patients who undergo surgery for colorectal cancer.

Year:

2025

Background: The prognostic relationship between diet and endometrial cancer survival remains largely unknown. We sought to determine pre- and post-diagnosis dietary composition, glycemic load (GL), inflammatory potential (dietary inflammatory index) and quality [Canadian Healthy Eating Index (C-HEI) 2005] associations with disease-free (DFS) and overall survival (OS) among endometrial cancer survivors. In addition, we assessed associations between dietary changes with OS and explored obesity/physical activity effect modification. Methods: Survivors, diagnosed in Alberta, Canada between 2002 and 2006, completed past-year, food-frequency questionnaires at-diagnosis ( n = 503) and 3-year follow-up ( n = 395). Participants were followed to death or January 2022. Cox proportional regression estimated HR [95% confidence intervals (CI)] for dietary survival associations. Results: During 16.9 median years of follow-up, 138 participants had a DFS event and 120 died. Lower pre-diagnosis GL (HR T1vsT3 , 0.49; 95% CI, 0.25–0.97) and greater post-diagnosis energy intakes (EI) from total- and monounsaturated-fat (HR T3vsT1 , 0.48; 95% CI, 0.26–0.87) were associated with better OS. Higher pre-diagnosis C-HEI, less inflammatory diets and lower added sugar intakes were nonlinearly associated with better DFS. Consistently low pre- to post-diagnosis EI from carbohydrates and total-fats were associated with better (HR, 0.36; 95% CI, 0.18–0.72) and worse (HR, 2.26; 95% CI, 1.21–4.20) OS, respectively. Decreased pre- to post-diagnosis C-HEI was associated with worse OS. In stratified analysis, healthy diets were most beneficial for survivors with obesity and physical inactivity. Conclusions: Adherence to higher quality dietary patterns were associated with better survival. Impact: Our study provides novel evidence that both pre- and post-diagnosis diet are important prognostic factors for endometrial cancer survivors. Post-diagnosis survival associations with diet composition and quality highlight the potential for future interventions.

Year:

2025

Disease-free and overall survival outcomes for pre-diagnosis (n=503) and post-diagnosis (n=395) standard servings of major food groups in Canada's Food Guide in the Alberta Endometrial Cancer Cohort, 2002–2022

Year:

2025

Background: Interventions targeting moderate-to-vigorous physical activity (MVPA) may be a catalyst for improving other lifestyle behaviors in breast cancer survivors (BCS). We examined whether Fit2Thrive, an mHealth MVPA intervention, influenced adherence to cancer prevention recommendations. Methods: BCSs ( N = 269; age, mean = 52.9; SD = 9.9) received a 12-week mHealth MVPA intervention and were randomized to “on” or “off” level of five intervention components. The World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) score was calculated (0 = high cancer risk, 6 = low cancer risk) based on cancer prevention recommendations: sugar-sweetened beverages, fast food, fruit/vegetable intake, body mass index, alcohol consumption, and MVPA (baseline, 12 weeks, and 24 weeks). Mixed-effects models examined changes in the WCRF/AICR score and each risk factor and the effects of each intervention component (telephone support calls, Fitbit Buddy, tailored text messages, deluxe app, online gym) level on the WCRF/AICR score. Results: The WCRF/AICR total score significantly improved at 12 and 24 weeks ( P values P values P = 0.01). No changes in other risk factors were observed. Conclusions: Participation in a mHealth MVPA intervention may influence cancer risk in BCS and have effects on certain untargeted behaviors (fruit and vegetable consumption) but not on other risk factors (sugar-sweetened beverages, fast food, body mass index, alcohol consumption). Future work should explore how to maximize these effects and determine if resource-efficient dietary intervention components improve cancer outcomes. Impact: Understanding the impact of an mHealth MVPA intervention on untargeted dietary behaviors may guide the development of scalable interventions targeting lifestyle behaviors.

Year:

2025

BACKGROUND Chronic fatigue (CF) is a highly disabling late effect after cancer, affecting 25% to 40% of lymphoma survivors years after cancer treatment. There is a lack of randomized controlled trials testing interventions to reduce fatigue levels among survivors with CF. OBJECTIVE The primary aim of the Randomized Controlled Trial in Chronically Fatigued Lymphoma Survivors (REFUEL) is to examine the effects of a multidisciplinary intervention on the level of fatigue among lymphoma survivors with CF before and immediately after the intervention (3 months after randomization). Secondary aims are to (1) investigate the effects of the intervention on the level of fatigue 6 and 9 months after randomization and the effects on health-related quality of life (HRQoL); other patient-reported outcome measures; and physical fitness 3, 6, and 9 months after randomization; (2) evaluate the cost-utility of the intervention; (3) examine the effect of the intervention on HRQoL among the survivors’ partners; and (4) investigate the long-term perceived benefits and daily use of acquired self-management strategies, as well as measure changes in fatigue, daily functioning, HRQoL, mental health, and work-life balance management within each group at 1- and 2-year follow-ups. METHODS The REFUEL trial is a 2-armed randomized controlled trial. Lymphoma survivors (2-12 years after diagnosis) with CF are randomly allocated to a 12-week multidisciplinary intervention including patient education, physical exercise, a cognitive behavioral therapy–based group program, and individual nutrition counseling or to usual care. Fatigue is measured by the Chalder Fatigue Questionnaire. Other patient-reported outcome measures are measured by validated questionnaires (eg, the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire, the Patient Health Questionnaire-9, and the Generalized Anxiety Disorder-7). Cardiorespiratory fitness is measured as peak oxygen consumption during a cardiopulmonary exercise test or indirectly using a modified Balke treadmill protocol. Muscle strength is assessed by push-ups and leg press. The primary analyses will be performed using a generalized linear mixed model for repeated measures, with an intention-to-treat approach. RESULTS A total of 150 survivors were included from December 2021 to March 2023. Three-month postrandomization assessments were completed in June 2023 and 2-year follow-up assessments were completed in June 2025. CONCLUSIONS The REFUEL trial will provide new and highly needed scientific evidence about the effects of a multidisciplinary intervention on the level of fatigue and secondary outcomes regarding HRQoL aspects among lymphoma survivors with CF. CLINICALTRIAL ClinicalTrials.gov NCT05130099; https://www.clinicaltrials.gov/study/NCT05130099 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/69336

Year:

2024

Background This study examined associations of device‐measured physical activity and sedentary time with quality of life (QOL) and fatigue in newly diagnosed breast cancer patients in the Alberta Moving Beyond Breast Cancer (AMBER) cohort study. Methods After diagnosis, 1409 participants completed the SF‐36 version 2 and the Fatigue Scale, wore an ActiGraph device on their right hip to measure physical activity, and an activPAL device on their thigh to measure sedentary time (sitting/lying) and steps. ActiGraph data was analyzed using a hybrid machine learning method (R Sojourn package, Soj3x) and activPAL data were analyzed using activPAL algorithms (PAL Software version 8). Quantile regression was used to examine cross‐sectional associations of QOL and fatigue with steps, physical activity, and sedentary hours at the 25th, 50th, and 75th percentiles of the QOL and fatigue distributions. Results Total daily moderate and vigorous physical activity (MVPA) hours was positively associated with better physical QOL at the 25th (β = 2.14, p = <.001), 50th (β = 1.98, p = <.001), and 75th percentiles (β = 1.25, p = .003); better mental QOL at the 25th (β = 1.73, p = .05) and 50th percentiles (β = 1.07, p = .03); and less fatigue at the 25th (β = 4.44, p < .001), 50th (β = 3.08, p = <.001), and 75th percentiles (β = 1.51, p = <.001). Similar patterns of associations were observed for daily steps. Total sedentary hours was associated with worse fatigue at the 25th (β = −0.58, p = .05), 50th (β = −0.39, p = .06), and 75th percentiles (β = −0.24, p = .02). Sedentary hours were not associated with physical or mental QOL. Conclusions MVPA and steps were associated with better physical and mental QOL and less fatigue in newly diagnosed breast cancer patients. Higher sedentary time was associated with greater fatigue symptoms.

Year:

2022

Collaborators (23)

David Cella

-

UNITED STATES
View details

Rune Blomhoff

Professor

University of Oslo

NORWAY
View details

Justin Jeon

Professor

Yonsei University

SOUTH KOREA
View details

Jing Song

Northwestern University

UNITED STATES
View details

Linda Cook

Professor

University of Colorado Cancer Center

UNITED STATES
View details

Alexander Fosså

Oslo University Hospital

NORWAY
View details

Mi Kyung Lee

Research Professor

Yonsei University

SOUTH KOREA
View details

Synne-Kristin Hoffart Bøhn

Oslo University Hospital

NORWAY
View details

Hanne Cathrine Lie

Associate Professor

University of Oslo

NORWAY
View details

Dong Hoon Lee

Assistant Professor

Yonsei University

SOUTH KOREA
View details

Lene Thorsen

Senior researcher, PhD

Oslo University Hospital

NORWAY
View details

Jessica McNeil

Assistant Professor

University of North Carolina at Greensboro

UNITED STATES
View details

Jean Reading

Assistant Professor

The University of Illinois at Chicago

UNITED STATES
View details

Frank J Penedo

Professor

University of Miami

UNITED STATES
View details

Siobhan M. Phillips

Program Co-Lead

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Byung Soh Min

Yonsei University Health System

SOUTH KOREA
View details

Bonnie Spring

Krafft Professor of Behavioral Sciences and Social Medicine and Director, Florida Blue Center for Rural Health Research and Policy

Northwestern University

UNITED STATES
View details

Seung Yoon Yang

Assistant professor

Yonsei University Health System

SOUTH KOREA
View details

Line Merethe Oldervoll

University of Bergen

NORWAY
View details

Nam Kyu Kim

Yonsei University College of Medicine

SOUTH KOREA
View details

Truls Raastad

Professor

Norwegian School of Sport Sciences

NORWAY
View details

Torbjørn Wisløff

Research Professor

-

NORWAY
View details

Juned Siddique

Northwestern University

UNITED STATES
View details